Preparation of a Burkholderia Mallei Vaccine

Abstract

Glanders, caused by Burkholderia mallei, is a significant disease for humans due to the serious nature of the infection. It is recognized that B. mallei is an organism with tremendous infectivity that poses a significant hazard to humans exposed to aerosols containing this organism. Our knowledge of the pathogenesis of disease due to B. mallei is lacking. At present, no effective vaccines are available against this organism, and information on the treatment of this organism with antibiotic therapy is also not available. The basic studies that we are performing on the pathogenesis of disease due to B. mallei are acutely needed, and the information gained from these studies will provide a knowledge base that is required to rationally design new modes of therapy directed against this organism. The long-term objective of our research is to define at a molecular level the pathogenesis of disease due to B. mallei and to develop immunoprotective vaccines against these organisms for use in humans.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2001
Accession Number
ADA390664

Entities

People

  • Donald E. Woods

Tags

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • Bacteria
  • Bacterial Infections
  • Bacterial Proteins
  • Bacteriology
  • Biomedical And Dental Materials
  • Cells
  • Chemistry
  • Dna Sequence Analysis
  • Genetic Engineering
  • Genetics
  • Health Services
  • Infection
  • Microbial Genetics
  • Microbiology
  • Polymeric Films
  • Proteins

Fields of Study

  • Medicine

Readers

  • Computational Modeling and Simulation
  • Immunology
  • Microbial Pathology

Technology Areas

  • Biotechnology